David M. Stack - Jun 9, 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: CEO and Chairman, Director
Signature: /s/ Kristen Williams, Attorney-in-Fact
Stock symbol: PCRX
Transactions as of: Jun 9, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/11/2021, 08:38 PM
Previous filing: Jun 8, 2021
Next filing: Jun 16, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Award	$0	+17.8K	+29.11%	$0.00	79K	Jun 9, 2021	Direct	F1
holding	PCRX	Common Stock						97.3K	Jun 9, 2021	By Three Colleens Investment, LLC	F2
holding	PCRX	Common Stock						18.6K	Jun 9, 2021	By Stack Schroon Mohawk FLP	F2
holding	PCRX	Common Stock						315	Jun 9, 2021	LCK Investment LLC	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCRX	Stock Option (Right to Buy)	Award	$0	+133K		$0.00	133K	Jun 9, 2021	Common Stock	133K	$60.96	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
F2	Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
F3	The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.